Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Regulatory Filings 2018

Sep 7, 2018

61176_rns_2018-09-07_c1b7d2aa-f2ac-4628-b2c0-8ffc20211a47.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Biocon Limited

www;biocon.com

20th KM Hosur Road Electronics City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417

Date of submission: September 07, 2018

To To
'The Secretary The Secretary
Listing Department Listing Department
BSE Limited National Stock Exchangeof India Limited
Department of CorporateServices Exchange Plaza, Bandra Kurla Complex
Phiroze JeejeebhoyTowers,, Mumbai —400 050
Dalal Street, Mumbai —-400 001 Scrip Code- BIOCON
Scrip Code -532523

Dear Sir/Madam,

Sub: Meetings conducted on September 06, 2018, with Institutional Investors/Research Analysts. Ref: Regulations 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that meetings with following Institutional Investors/Research Analysts were conducted on September 06, 2018 at New York City.

  • Oppenheimer Funds
  • Driehaus Capital Management
  • Consilium Investment Management
  • Fiera Capital
  • New Vernon Advisors
  • Credit Capital Investments
  • TimesSquare Capital Management
  • Diamond HiII Capital Management
  • Channing Global Advisors EDWNP'WPWN!'
  • Nuveen Asset Management
  • Capital International HH 5'9

We request you to kindly take this to your record as per the requirement of Listing Regulations and oblige.

Thanking You, Yours faithfully For Biocon Limited

Satish Kumar SS Company Secretary and Compliance Officer